Efficacy of Nano-Ivermectin Impregnated Masks in Prevention of Covid-19 Among Healthy Contacts and Medical Staff
NCT04723459 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150
Last updated 2021-03-17
Summary
Antiviral efficacy of Ivermectin against Covid-19 in vitro was stated by many stusies all over the world with decreased effecacy in vivo so ,usage of masks impregnated into nano Ivermectin solution will theoretically increase the protective action of the ordinary masks
Conditions
Interventions
- OTHER
-
ivermectin impregnated mask
mask with ivermectin nano solution
Sponsors & Collaborators
-
South Valley University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-01-23
- Primary Completion
- 2021-02-19
- Completion
- 2021-03-28
Countries
- Egypt
Study Locations
More Related Trials
-
Efficacy and Safety of Recovered Covid 19 Plasma Transfusion to Covid 19 Severly Ill Patients
NCT04530370 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
The Efficacy of Ivermectin in Larger Doses in COVID-19 Treatment
NCT04351347 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Ivermectin In Treatment of COVID 19 Patients
NCT04425707 ·Status: UNKNOWN ·Phase: NA
-
A Study to Compare the Efficacy and Safety of Different Doses of Ivermectin for COVID-19
NCT04431466 ·Status: TERMINATED ·Phase: PHASE2
-
Ivermectin Versus Standard Treatment in Mild COVID-19
NCT04937569 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy of Ivermectin in COVID-19
NCT04392713 ·Status: UNKNOWN ·Phase: NA
-
Outpatient Use of Ivermectin in COVID-19
NCT04530474 ·Status: WITHDRAWN ·Phase: PHASE3
-
Novel Regimens in COVID-19 Treatment
NCT04382846 ·Status: RECRUITING ·Phase: PHASE3
-
Efficacy, Safety and Tolerability of Ivermectin in Subjects Infected With SARS-CoV-2 With or Without Symptoms
NCT04407507 ·Status: COMPLETED ·Phase: PHASE2
-
Safety & Efficacy of Low Dose Aspirin / Ivermectin Combination Therapy for Treatment of Covid-19 Patients
NCT04768179 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of COVID-19
NCT04292340 ·Status: UNKNOWN
-
Ivermectin in Adults With Severe COVID-19.
NCT04602507 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy of Ivermectin in Outpatients With Non-severe COVID-19
NCT04834115 ·Status: UNKNOWN ·Phase: PHASE3
-
New Antiviral Drugs for Treatment of COVID-19
NCT04392427 ·Status: UNKNOWN ·Phase: PHASE3
-
Ivermectin Role in Covid-19 Clinical Trial
NCT04746365 ·Status: COMPLETED ·Phase: PHASE4
-
Convalescent Plasma to Limit SARS-CoV-2 Associated Complications
NCT04373460 ·Status: COMPLETED ·Phase: PHASE2
-
ACTIV-6: COVID-19 Study of Repurposed Medications - Arm A (Ivermectin 400)
NCT05736861 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of Convalescent Plasma in Hospitalized Patients With COVID-19
NCT04764747 ·Status: COMPLETED
-
COVID-19: Laser Interferometry for Rapid Single Coronavirus Detection
NCT04401644 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of Ethanol Inhalation on COVID-19 Treatment (a Clinical Trial Study)
NCT05268419 ·Status: COMPLETED ·Phase: PHASE3
-
Ivermectin and Nitazoxanide Combination Therapy for COVID-19
NCT04360356 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Utilizing the Crosstalk Among Aerosolized Phenformin , Methylene Blue, Photodynamic Therapy , Zinc and Potassium for Treating Severe COVID-19 Infection and Its Inflammatory Complication
NCT05003492 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Study in Participants With Early Stage Coronavirus Disease 2019 (COVID-19) to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by Inhalation
NCT04539262 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of Efficacy and Safety of MAS825 in Patients With COVID-19
NCT04382651 ·Status: COMPLETED ·Phase: PHASE2
-
COVID-19 Convalescent Plasma Treatment in SARS-CoV-2 Infected Patients
NCT04474340 ·Status: UNKNOWN ·Phase: PHASE1